Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-17 2:56 pm Purchase |
2024-03-04 | 13G | Achieve Life Sciences, Inc. ACHV |
Propel Bio Management LLC | 2,334,176 6.810% |
2,334,176 (New Position) |
Filing History |
| 2024-02-22 2:26 pm Purchase |
2024-02-09 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Management LLC | 8,071,526 10.500% |
3,314,144 (+69.66%) |
Filing History |
| 2023-11-02 9:54 pm Purchase |
2023-11-02 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 179,174 12.130% |
9,275 (+5.46%) |
Filing History |
| 2023-10-20 4:29 pm Purchase |
2023-10-18 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 169,900 11.510% |
9,102 (+5.66%) |
Filing History |
| 2023-09-28 4:54 pm Purchase |
2023-09-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 160,798 10.900% |
81,059 (+101.66%) |
Filing History |
| 2023-08-15 06:00 am Purchase |
2023-08-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 79,739 5.400% |
79,739 (New Position) |
Filing History |
| 2023-05-02 1:24 pm Purchase |
2023-02-28 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Management LLC | 4,757,382 9.900% |
4,757,382 (New Position) |
Filing History |